A Phase I Clinical Study of NS-025 in Healthy Subjects
Phase 1
Recruiting
- Conditions
- Healthy volunteer
- Registration Number
- JPRN-jRCT2031220474
- Lead Sponsor
- Higashioka Masaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
1) Provided written informed consent
2) Japanese male subjects
3) White male subjects
4) Japanese female subjects of non-childbearing potential
Exclusion Criteria
1) Subjects with a history of surgery which may have an impact on drug absorption
2) Subjects with a history of allergy or hypersensitivity to drugs or foods
3) Subjects who collected 200 mL or more of whole blood or component blood within 2 weeks before administration of the study drug
4) Subjects who have received other investigational products within 16 weeks (112 days) prior to the first investigational product administration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method